CHAIR
:
SPEAKER
(S):
George Vradenburg, (SPKSUP), Co-Founder/President, USAgainstAlzheimer's, United States
Rudolph E. Tanzi, PhD (SPKSUP), Head, Genetics and Aging Research Unit; Prof, Neurology, Harvard Medical School, Massachusetts General Hospital, United States
Nicholas A. Kozauer, MD (SPKAGY), Medical Officer, Office of New Drugs, CDER, FDA, United States
Peter Neumann,
DrSc (SPKSUP), Prof of Medicine; Director, Center for Evaluation of Value and Risk in Health,
Tufts Medical Center, United States
His research focuses on the use of comparative effectiveness research and cost-effectiveness analysis in health care decision making. He is the founder and director of the Cost-Effectiveness Registry (www.cearegistry.org), a comprehensive database of cost-effectiveness analyses in health care.
|
Reisa A. Sperling,
MD (SPKSUP), Director; Professor, Neurology, Harvard Medical School,
Brigham and Women's Hospital and Massachusetts General Hospital, United States
Prof in Neurology at Harvard and the Dir of the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital. She is the Principal Investigator on the NIA Program Project funded Harvard Aging Brain Study and the Dir of the Alzheimer’s Disease Neuroimaging Program at Mass General.
|
Description
A visionary perspective on how industry and health authorities are working to help move towards a cure for Alzheimer's disease will be provided by a distinguished panel of experts in this inaugural forum. According to the World Alzheimer's Report, currently 36 million have dementia worldwide, and the numbers will increase to 66 million people living with dementia by 2030 and 115 million by 2050. This forum will provide a comprehensive picture of the global impact of this disease and the progress towards earlier detection and meaningful therapeutic intervention. It will also look at key strategies that governments, advocacy groups, and industry are taking to elevate Alzheimer's disease on the global agenda to ensure that society is prepared to address the growing epidemic. This opening forum serves as the foundation for more focused sessions on the patient and caregiver perspectives, and on how to advance clinical development.